Search Results 701-710 of 24065 for prostate cancer

  1. David D. Thiel, M.D. - Doctors and Medical Staff - Mayo Clinic

    Laparoscopic and robotic surgery for malignant and benign urologic conditions · Complex kidney surgery (for tumors, stones, obstruction) · Prostate cancer ...

  2. Contact - Department of Urology - Mayo Clinic Research

    Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. ... cancer, prostate cancer and kidney cancer. Our team of physician- ...

  3. Testicular cancer - Diagnosis and treatment - Mayo Clinic

    Learn about cancer that starts in the testicles. Treatments include surgery, chemotherapy and radiation therapy.

  4. Piflufolastat f 18 (intravenous route) - Side effects & uses - Mayo Clinic

    ... prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. It is given in patients with suspected metastasis (cancer that has ...

  5. Clinical trials - Oncology (Medical)

    A Study to Collect Surgical Tumor Samples for Prostate Cancer-derived Tissue Graft. Rochester, Minn. The purposes of this study are to collect prostate ...

  6. Publications - Rumeal D. Whaley, M.D. - Mayo Clinic

    Prostate Cancer Prostatic Dis. 2025 Jun; 28 (2):506-508 Epub 2024 Feb 27. View PubMed; Gupta S, Dasari S, Shen W, Al-Kateb H, Barr Fritcher EG, Torell NR ...

  7. Olaparib (oral route) - Side effects & dosage - Mayo Clinic

    For ovarian cancer, fallopian tube cancer, pancreas cancer, primary peritoneal cancer, prostate cancer, or metastatic breast cancer: Adults—300 milligrams (mg) ...

  8. Mayo Clinic physicians present research findings at 2016 ASTRO Annual Meeting

    “Management of recurrent prostate cancer after radiation therapy depends on accurately identifying the site of the recurrent disease,” says William Parker, M.D. ...

  9. Genome Function, Stability and Nuclear Organization in Cancer: Veronica Rodriguez-Bravo - Mayo Clinic Research

    Learn how Mayo Clinic's Genome Function, Stability and Nuclear Organization in Cancer Lab exposes mechanisms that drive therapy-resistant prostate cancer.

  10. Men Ages 40-49 Could Skip Annual PSA Screening - Mayo Clinic News Network

    The study also found that participants with low PSAs, below 1.0 ng/ml, were also very unlikely to develop even low-risk prostate cancer. Soundbites with ...